AVICENNA’S LEGACY AND THE MODERN CARDIO-HEPATIC AXIS:  A MULTIMARKER APPROACH TO LIVER FIBROSIS ASSESSMENT IN  HFpEF AND MASLD

dc.contributor.author	Buvamukhamedova N.T., Parpibayeva D.A.
dc.date.accessioned	2026-11-03T05:28:54Z
dc.date.available	2026-11-03T05:28:54Z
dc.date.issued	2026-08-16
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/5677
dc.description.abstract	Purpose of the study: To evaluate the diagnostic value of an integrated multimarker strategy based on NT-proBNP, PRO-C3, and cytokeratin-18 fragment (CK-18, M30) for non-invasive assessment of liver fibrosis in patients with stage IIA HFpEF and concomitant MASLD	en_US
dc.language.iso	en_US	en_US
dc.publisher	O'zbekiston, Buxoro (ABU ALI IBN SINO: ZAMONAVIY TIBBIYOT VA XALQ TABOBATI – INNOVATSIYALAR VA INVESTITSIYALAR) XIV XALQARO IBN SINO OʻQISHLARI–ILMIY-AMALIY KONFERENSIYA MAQOLALAR TOʻPLAMI	en_US
dc.title	AVICENNA’S LEGACY AND THE MODERN CARDIO-HEPATIC AXIS: A MULTIMARKER APPROACH TO LIVER FIBROSIS ASSESSMENT IN HFpEF AND MASLD	en_US
dc.type	Thesis	en_US